๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Mutagen sensitivity as a marker of cancer susceptibility

โœ Scribed by Margaret R. Spitz; Xifeng Wu; Hong Jiang; T.C. Hsu


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
499 KB
Volume
63
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

โœฆ Synopsis


Modulation of environmental exposures by host genetic factors may explain interindividual variation in susceptibility to carcinogenesis. One determinant of susceptibility is mutagen sensitivity measured by the frequency of bteomycin-induced breaks i n an in vitro lymphocyte assay. Mutagen sensitivity is a significant predictor of aerodigestive tract cancer risk. In this case-control study of lung-cancer susceptibility markers, 54% of 132 lung-cancer cases had mutagen-sensitivity scores greater than or equal to 1 breakkell, compared with only 22% of 232 controls. The mean breakskell value (zSE) for the 88 African-American cases was 1.11 (i0.60), compared with 0.82 (20.49) for the 121 controls ( P < 0.001). For the 44 Mexican-American cases and 111 controls, the comparable values were 1.1 1 (+0.52) and 0.76 (10.38), respectively. The overall odds ratio (OR) for mutagen sensitivity (dichotomized at 2 1 break/cellj, after adjusting for ethnicity and smoking status, was 3.62 (9So/o confidence limits [CL] = 2.2, 5.9). For current smokers the adjusted risk associated with mutagen sensitivity was 2.52 (1.2, 5.3). For former smokers, the comparable OR (95% CL) was 6.1 9 (2.7, 14.1). The risk estimate for those under 61 years of age was 4.85 (2.3, 10.4), compared with 2.85 (1 .5,5.6) for older subjects. The risk also appeared to be higher for lighter smokers (<20 cigarettes daily) than heavier smokers (ORs = 5.72 and 3.20, respectively). The ethnicity-adjusted ORs by quartile of breakskell were 1 .O, 1.40, 2.46. and 4.80; the trend test was significant at P < 0.001. The joint effects of mutagen sensitivity and former smoking, current smoking, or heavy smoking were greater than additive, although the interaction terms were not statistically significmt in the logistic model. Mutagen sensitivity may therefore be a useful member of a panel of susceptibility markers for detining high-risk subgroups for chemoprevention trials. J. Cell.


๐Ÿ“œ SIMILAR VOLUMES


p53 As a mutagen test in breast cancer
โœ Kathleen A. Hill; Steve S. Sommer ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 145 KB
Nucleotide excision repair as a marker f
โœ Ana S. Neumann; Erich M. Sturgis; Qingyi Wei ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 287 KB

DNA repair is a complicated biological process consisting of several distinct pathways that play a central role in maintaining genomic stability. Research on DNA repair and cancer risk is a vital, emerging field that recently has seen rapid advances facilitated by the completion of the Human Genome

DNA adducts as a marker for cancer risk?
โœ Kari Hemminki; Mikko Koskinen; Chunyan Zhao ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 35 KB